氟伐他汀对糖尿病大鼠睾丸损伤的保护作用及其机制研究
|
摘要
目的通过建立雄性糖尿病大鼠生殖损伤的模型,观察氟伐他汀对糖尿病大鼠睾丸损伤的保护作用,并探讨氟伐他汀对糖尿病大鼠睾丸损伤保护作用的可能机制。
方法选用SPF级雄性SD大鼠86只,随机取10只做为正常对照组,其余大鼠均腹腔注射STZ(65mg/kg)诱导糖尿病大鼠模型。将造模成功大鼠按血糖、体重均匀分为糖尿病模型对照组(DM)、氟伐他汀(6、18mg/kg)组和胰岛素组。氟伐他汀组每天灌胃1次,正常对照组及糖尿病模型组给予等体积生理盐水灌胃,胰岛素组给予精蛋白锌胰岛素皮下注射2U·kg-1·d-1,连续给药8周。8周末,处死动物,留取血清及睾丸组织,行血清睾酮(T)、睾丸组织MDA、SOD、GSH-Px检测,并在光镜下观察HE染色、TUNEL染色及免疫组织化学(Bcl-2,Bax)等指标,透射电镜下观察睾丸组织超微结构改变。
结果
1.氟伐他汀对糖尿病大鼠一般情况的影响:实验期间,糖尿病模型组大鼠除“三多一少”现象外,还出现多系统并发症的表现,死亡较多(41.6%);与糖尿病组比较,氟伐他汀各剂量组对外界反应相对灵敏,并发症程度较轻,死亡相对较少(36.4%和27.3%);胰岛素组大鼠的一般情况明显改善,死亡较少(27.3%)。
2.氟伐他汀对糖尿病大鼠血糖、体重的影响:经8周药物干预后,糖尿病组大鼠空腹血糖显著高于正常组(P<0.01);氟伐他汀各组空腹血糖较糖尿病组有不同程度的下降(P<0.01);胰岛素组与正常组空腹血糖无显著性差异(P>0.05)。与正常组相比,糖尿病组大鼠体重显著减轻(P<0.01);氟伐他汀各组与糖尿病组大鼠体重无显著性差异(P>0.05);胰岛素组大鼠体重较糖尿病组显著增加(P<0.01),但不及正常组(P<0.01)。
3.氟伐他汀对糖尿病大鼠睾丸质量、睾丸脏器系数的影响:糖尿病组大鼠睾丸质量、脏器系数较正常组显著降低(P<0.01);氟伐他汀各组睾丸质量及脏器系数高于糖尿病组,且18mg/kg组与糖尿病组存在显著性差异(P<0.01);胰岛素组大鼠睾丸质量低于正常组(P<0.01),但两组脏器系数无显著性差异(P>0.05)。
4.氟伐他汀对糖尿病大鼠精子参数的影响:糖尿病组大鼠精子数量、精子活率显著少于正常组(P<0.01);氟伐他汀6mg/kg组精子数量、精子活率与糖尿病组无显著性差异(P>0.05),氟伐他汀18mg/kg组精子数量、精子活率均较糖尿病组显著增高(P<0.05或P<0.01),但不及胰岛素组(P<0.01)。胰岛素组精子数量、精子活率低于正常组(P<0.01)。
5.氟伐他汀对糖尿病大鼠睾丸组织HE染色的影响:光镜下,正常组大鼠睾丸曲细精管饱满,各级生精细胞排列整齐,管腔内可见密集精子;糖尿病模型组大鼠曲细精管明显萎缩,生精细胞脱落、数量显著减少,大部分管腔内未见精子;氟伐他汀组曲细精管结构基本完整,6mg/kg组管腔内可见精子细胞核分裂像,18mg/kg组管腔内可见少量精子;胰岛素组曲细精管及各级生精细胞形态基本正常,管腔内可见较多精子。
6.氟伐他汀对糖尿病大鼠睾丸生精细胞TUNEL染色的影响:凋亡细胞表达糖尿病组最多,并显著高于其余各组(P<0.01);氟伐他汀干预后,凋亡生精细胞数量较糖尿病组明显减少(P<0.01),且18mg/kg组优于6mg/kg组,但不及胰岛素组;胰岛素组凋亡细胞数量与正常组相近(P>0.05)。
7.氟伐他汀对糖尿病大鼠睾丸组织电镜下超微结构的影响:糖尿病组大鼠睾丸间质细胞体积缩小,细胞质减少,线粒体减少、嵴溶解,内质网扩张,脂滴增加,间质细胞核固缩,染色质呈块状浓集;间质微血管内皮细胞增生、肿胀,基底膜显著增厚,可见大量纤维素样物质沉积。氟伐他汀组间质细胞细胞器增多,线粒体嵴结构较清晰,内质网增多,脂滴减少,细胞核染色质浓集、边集现象好转;间质微血管管腔通畅,血管内皮细胞形态明显好转,血管基底膜增厚现象明显减轻,纤维素样沉积明显减少,且18mg/ kg组优于6mg/kg组,接近于正常组。胰岛素组间质细胞、间质微血管超微结构与正常组接近。
8.氟伐他汀对糖尿病大鼠血清睾酮的影响:糖尿病组大鼠睾酮水平较正常组显著降低(P<0.01)。氟伐他汀18mg/kg组睾酮水平较糖尿病组显著增高(P<0.01),但不及胰岛素组;胰岛素组睾酮水平低于正常组(P<0.05)。
9.氟伐他汀对糖尿病大鼠睾丸组织SOD、GSH-PX活性和MDA含量的影响:与正常组大鼠相比,糖尿病模型组大鼠SOD水平显著降低(P<0.01)、GSH-PX、MDA水平显著增高(P<0.01);与糖尿病组大鼠相比,氟伐他汀各组SOD水平显著增高(P<0.01或P<0.05),GSH-PX水平、MDA水平显著下降(P<0.05或P<0.01);氟伐他汀各组SOD、GSH-PX、MDA水平与胰岛素组间无显著性差异(P>0.05)。
10.氟伐他汀对糖尿病大鼠睾丸生精细胞Bax,Bcl-2免疫组化阳性细胞表达的影响:在正常组中,Bcl-2表达最明显,Bax表达最少,而糖尿病组较其余各组Bcl-2表达显著减少(P<0.01),Bax表达显著增加(P<0.01);氟伐他汀治疗组较糖尿病组Bcl-2表达显著增加,Bax表达显著减少(P<0.01),且18mg/kg组优于6mg/kg组。胰岛素组较氟伐他汀组Bcl-2表达增加、Bax表达减少(P<0.01),但与正常组比较还存在显著性差异(P<0.01)。
结论
1.氟伐他汀可减轻糖尿病大鼠的睾丸损伤,对睾丸组织具有保护作用。
2.氟伐他汀对糖尿病大鼠睾丸损伤的保护作用机制可能与减轻糖尿病大鼠睾丸组织氧化应激水平以及调节生精细胞Bax,Bcl-2阳性细胞表达等有关。
Objective To observe the protective effects of Fluvastatin on diabetic testis injury and explore the possible mechanism on the reproductive damage in diabetic male rats model.
Methods 86 SPF Male SD rats were used in the experiment , 10 rats were taken as normal control group, the others were induced to diabetic model by injected STZ (65mg/kg) in intraperitoneal. The successful model rats were divided into diabetic group (DM), fluvastatin (6,18 mg / kg) group and insulin group according to their blood glucose and body weights. Fluvastatin groups were fed one time per day, the normal control group and diabetic model group were given equal volume of saline, and the insulin group was given protamine zinc insulin 2U·kg once a day in subcutaneously for 8 weeks. Animals were sacrificed after 8 weeks, the specimens of serum and testicular tissue from the rats were collected, the serum testosterone (T) and MDA, SOD, GSH-Px in testicular tissue were detected. The HE staining ,TUNEL staining and immunohistochemistry (Bcl-2 , Bax) indicators were observed under the light microscope, and the ultrastructural changes of testicular tissue were observed by transmission electron microscope.
Results
1.Effects of fluvastatin on the general situation of diabetic rats: during the experimental period, diabetic rats group showed typical symptoms of the complications of diabetes and higher mortality (41.6%). Compare to the diabetic group, the response of rats to the outside world was more sensitive, and with lesser complications and death rate (36.4% and 27.3%) in each dose of fluvastatin group. In insulin group, the general situation of rats significantly improved, and with lesser death ( 27.3%).
2. Effects of fluvastatin on blood glucose and body weight: after 8 weeks of drug intervention, fasting blood glucose level was significantly higher in the diabetic group than the normal control group (P <0.01); fasting blood glucose level in fluvastatin groups had different extent of decline compared with diabetic group (P <0.01); fasting blood glucose level had no significant difference in insulin group and normal control group (P> 0.05). Compared with normal control group, body weight reduced significantly in diabetic model rats (P <0.01); in each group of fluvastatin and diabetic rats there was no significant difference in body weight (P> 0.05); body weight of insulin group was significantly increased (P <0.01), but still less than the normal group (P <0.01).
3. Effects of fluvastatin on diabetic rats testis mass and testicular coefficient: the quality and the coefficient of diabetic model rat testis were significantly lower than the normal control group (P <0.01); testis mass and coefficient in fluvastatin groups were higher than the diabetic model group and 18mg/kg group was significantly different with the diabetic mode group (P <0.01); testis mass was lower in insulin group than normal control group (P <0.01), but there were no significant difference in testis coefficient (P> 0.05).
4. Effects of fluvastatin on sperm parameters in diabetic rats: the sperm count and sperm motility in diabetic model group were significantly less than the normal control group (P <0.01); fluvastatin 6mg/kg group had no significant difference with the diabetic mode group (P> 0.05) of sperm count and sperm motility rate, fluvastatin 18mg/kg group was significantly higher than the diabetic model group (P <0.05 or P <0.01)on these, but less than insulin group (P <0.01). Insulin group‘s sperm count and sperm motility had significant difference with the normal group (P <0.01).
5. Effects of fluvastatin on HE staining of diabetic rat’s testicular tissue:under the light microscopy, the normal rat’s testis seminiferous tubules were full and neatly arranged in spermatogenic cell lumen and the sperm density; the diabetic model group rats’seminiferous tubules were atrophied, germ cells were significant reduced, no sperm in most of the lumens; structure of seminiferous tubules were integrity in fluvastatin groups: mitotic phase of sperm could be seen in 6mg/kg group and some sperms could be seen in 18mg/kg group. The morphologies of spermatogenic cells and seminiferous tubules in insulin group looked like as normal group, more sperm could be seen in the seminiferous tubules.
6. Effects of fluvastatin on TUNEL staining of diabetic rats’spermatogenic cells: the amount of apoptotic cells was the most in the diabetic group, and significantly higher than other groups (P <0.01). After the intervention of fluvastatin, the number of apoptotic spermatogenic cells significantly decreased compared with diabetic model group (P <0.01), and it was better in the 18mg / kg group than 6mg/kg group, but still more than insulin group; The number of apoptotic cells in insulin group was similar to the normal group (P> 0.05).
7. Effects of fluvastatin on testicular tissue ultrastructure of diabetic rats under the electron microscope: in diabetic rats, Leydig cells were shrunk, cytoplasmic reduced, mitochondrial reduced and cristae dissolved, endoplasmic reticulums were expanded, lipid droplets were increased , Leydig cell nuclear pyknosis , chromatin gathered; Interstitial microvascular endothelial cell proliferated and swelled, basement membrane thickened significantly, showing that a large number of cellulose-like substance deposited. In the fluvastatin group ,organelles increased in Leydig cells ,the structure of mitochondrial cristae became more clear, endoplasmic reticulum increased, lipid droplets, the Phenomenon of Leydig cell nuclear pyknosis and Chromatin gathered better than the diabetic group; The interstitial capillary lumen patency, significantly improved in vascular endothelial cells, vascular basement membrane thickening and fibrinoid deposition was significantly reduced. And the 18mg/kg group was better than 6mg/kg group, close to the normal group.The ultrastructure of interstitial cells and interstitial microvasculars in the Insulin group were close to the normal group.
8. Effects of fluvastatin on serum testosterone levels in diabetic rats: testosterone levels in diabetic rats were significantly lower than the normal rats (P <0.01). Testosterone levels were higher in fluvastatin 18mg/kg group than the diabetic model group (P <0.01), but less than insulin group. The testosterone levels of insulin group were lower than the normal group (P <0.05).
9. Effects of fluvastatin on testis tissue SOD, GSH-PX activity and MDA content in diabetic rats: compared with normal rats, SOD levels were significantly lower in diabetic rats than normal rats (P <0.01), GSH-PX and MDA levels were significantly higher than normal rats (P <0.01). SOD were significantly higher in the fluvastatin groups than the diabetic group (P <0.01 or P <0.05), GSH-PX level and MDA level were decreased significantly than the diabetic group (P < 0.05 or P <0.01); The fluvastatin groups have no significant differences with the Insulin group in SOD, GSH-PX and MDA level (P> 0.05).
10. Effects of fluvastatin on Bax, Bcl-2 positive immunohistochemical expression of spermatogenic cells in diabetic rats: In the normal group, Bcl-2 expression was the most and Bax expression was the least, the Bcl-2 expression was significantly decreased and Bax expression was significantly increased in diabetic group than in the other groups (P <0.01). The Bcl-2 expression in fluvastatin group was significantly increased than in the diabetic group (P <0.01), and Bax expression was significantly decreased (P <0.01)than in the diabetic group, the 18mg / kg group was better than 6mg/kg group. Insulin group was better than the fluvastatin group (P <0.01), but there was significant difference with the normal group (P <0.01).
Conclusion
1.Fluvastatin can reduces testicular tissue Injury of diabetic rats, it has a protective effect on testicular tissue.
2.The Protective mechanism of fluvastatin on the testicular tissue in diabetic rats may related to the reduced oxidative stress and regulation of germ cell Bax, Bcl-2 positive cells
方法选用SPF级雄性SD大鼠86只,随机取10只做为正常对照组,其余大鼠均腹腔注射STZ(65mg/kg)诱导糖尿病大鼠模型。将造模成功大鼠按血糖、体重均匀分为糖尿病模型对照组(DM)、氟伐他汀(6、18mg/kg)组和胰岛素组。氟伐他汀组每天灌胃1次,正常对照组及糖尿病模型组给予等体积生理盐水灌胃,胰岛素组给予精蛋白锌胰岛素皮下注射2U·kg-1·d-1,连续给药8周。8周末,处死动物,留取血清及睾丸组织,行血清睾酮(T)、睾丸组织MDA、SOD、GSH-Px检测,并在光镜下观察HE染色、TUNEL染色及免疫组织化学(Bcl-2,Bax)等指标,透射电镜下观察睾丸组织超微结构改变。
结果
1.氟伐他汀对糖尿病大鼠一般情况的影响:实验期间,糖尿病模型组大鼠除“三多一少”现象外,还出现多系统并发症的表现,死亡较多(41.6%);与糖尿病组比较,氟伐他汀各剂量组对外界反应相对灵敏,并发症程度较轻,死亡相对较少(36.4%和27.3%);胰岛素组大鼠的一般情况明显改善,死亡较少(27.3%)。
2.氟伐他汀对糖尿病大鼠血糖、体重的影响:经8周药物干预后,糖尿病组大鼠空腹血糖显著高于正常组(P<0.01);氟伐他汀各组空腹血糖较糖尿病组有不同程度的下降(P<0.01);胰岛素组与正常组空腹血糖无显著性差异(P>0.05)。与正常组相比,糖尿病组大鼠体重显著减轻(P<0.01);氟伐他汀各组与糖尿病组大鼠体重无显著性差异(P>0.05);胰岛素组大鼠体重较糖尿病组显著增加(P<0.01),但不及正常组(P<0.01)。
3.氟伐他汀对糖尿病大鼠睾丸质量、睾丸脏器系数的影响:糖尿病组大鼠睾丸质量、脏器系数较正常组显著降低(P<0.01);氟伐他汀各组睾丸质量及脏器系数高于糖尿病组,且18mg/kg组与糖尿病组存在显著性差异(P<0.01);胰岛素组大鼠睾丸质量低于正常组(P<0.01),但两组脏器系数无显著性差异(P>0.05)。
4.氟伐他汀对糖尿病大鼠精子参数的影响:糖尿病组大鼠精子数量、精子活率显著少于正常组(P<0.01);氟伐他汀6mg/kg组精子数量、精子活率与糖尿病组无显著性差异(P>0.05),氟伐他汀18mg/kg组精子数量、精子活率均较糖尿病组显著增高(P<0.05或P<0.01),但不及胰岛素组(P<0.01)。胰岛素组精子数量、精子活率低于正常组(P<0.01)。
5.氟伐他汀对糖尿病大鼠睾丸组织HE染色的影响:光镜下,正常组大鼠睾丸曲细精管饱满,各级生精细胞排列整齐,管腔内可见密集精子;糖尿病模型组大鼠曲细精管明显萎缩,生精细胞脱落、数量显著减少,大部分管腔内未见精子;氟伐他汀组曲细精管结构基本完整,6mg/kg组管腔内可见精子细胞核分裂像,18mg/kg组管腔内可见少量精子;胰岛素组曲细精管及各级生精细胞形态基本正常,管腔内可见较多精子。
6.氟伐他汀对糖尿病大鼠睾丸生精细胞TUNEL染色的影响:凋亡细胞表达糖尿病组最多,并显著高于其余各组(P<0.01);氟伐他汀干预后,凋亡生精细胞数量较糖尿病组明显减少(P<0.01),且18mg/kg组优于6mg/kg组,但不及胰岛素组;胰岛素组凋亡细胞数量与正常组相近(P>0.05)。
7.氟伐他汀对糖尿病大鼠睾丸组织电镜下超微结构的影响:糖尿病组大鼠睾丸间质细胞体积缩小,细胞质减少,线粒体减少、嵴溶解,内质网扩张,脂滴增加,间质细胞核固缩,染色质呈块状浓集;间质微血管内皮细胞增生、肿胀,基底膜显著增厚,可见大量纤维素样物质沉积。氟伐他汀组间质细胞细胞器增多,线粒体嵴结构较清晰,内质网增多,脂滴减少,细胞核染色质浓集、边集现象好转;间质微血管管腔通畅,血管内皮细胞形态明显好转,血管基底膜增厚现象明显减轻,纤维素样沉积明显减少,且18mg/ kg组优于6mg/kg组,接近于正常组。胰岛素组间质细胞、间质微血管超微结构与正常组接近。
8.氟伐他汀对糖尿病大鼠血清睾酮的影响:糖尿病组大鼠睾酮水平较正常组显著降低(P<0.01)。氟伐他汀18mg/kg组睾酮水平较糖尿病组显著增高(P<0.01),但不及胰岛素组;胰岛素组睾酮水平低于正常组(P<0.05)。
9.氟伐他汀对糖尿病大鼠睾丸组织SOD、GSH-PX活性和MDA含量的影响:与正常组大鼠相比,糖尿病模型组大鼠SOD水平显著降低(P<0.01)、GSH-PX、MDA水平显著增高(P<0.01);与糖尿病组大鼠相比,氟伐他汀各组SOD水平显著增高(P<0.01或P<0.05),GSH-PX水平、MDA水平显著下降(P<0.05或P<0.01);氟伐他汀各组SOD、GSH-PX、MDA水平与胰岛素组间无显著性差异(P>0.05)。
10.氟伐他汀对糖尿病大鼠睾丸生精细胞Bax,Bcl-2免疫组化阳性细胞表达的影响:在正常组中,Bcl-2表达最明显,Bax表达最少,而糖尿病组较其余各组Bcl-2表达显著减少(P<0.01),Bax表达显著增加(P<0.01);氟伐他汀治疗组较糖尿病组Bcl-2表达显著增加,Bax表达显著减少(P<0.01),且18mg/kg组优于6mg/kg组。胰岛素组较氟伐他汀组Bcl-2表达增加、Bax表达减少(P<0.01),但与正常组比较还存在显著性差异(P<0.01)。
结论
1.氟伐他汀可减轻糖尿病大鼠的睾丸损伤,对睾丸组织具有保护作用。
2.氟伐他汀对糖尿病大鼠睾丸损伤的保护作用机制可能与减轻糖尿病大鼠睾丸组织氧化应激水平以及调节生精细胞Bax,Bcl-2阳性细胞表达等有关。
Objective To observe the protective effects of Fluvastatin on diabetic testis injury and explore the possible mechanism on the reproductive damage in diabetic male rats model.
Methods 86 SPF Male SD rats were used in the experiment , 10 rats were taken as normal control group, the others were induced to diabetic model by injected STZ (65mg/kg) in intraperitoneal. The successful model rats were divided into diabetic group (DM), fluvastatin (6,18 mg / kg) group and insulin group according to their blood glucose and body weights. Fluvastatin groups were fed one time per day, the normal control group and diabetic model group were given equal volume of saline, and the insulin group was given protamine zinc insulin 2U·kg once a day in subcutaneously for 8 weeks. Animals were sacrificed after 8 weeks, the specimens of serum and testicular tissue from the rats were collected, the serum testosterone (T) and MDA, SOD, GSH-Px in testicular tissue were detected. The HE staining ,TUNEL staining and immunohistochemistry (Bcl-2 , Bax) indicators were observed under the light microscope, and the ultrastructural changes of testicular tissue were observed by transmission electron microscope.
Results
1.Effects of fluvastatin on the general situation of diabetic rats: during the experimental period, diabetic rats group showed typical symptoms of the complications of diabetes and higher mortality (41.6%). Compare to the diabetic group, the response of rats to the outside world was more sensitive, and with lesser complications and death rate (36.4% and 27.3%) in each dose of fluvastatin group. In insulin group, the general situation of rats significantly improved, and with lesser death ( 27.3%).
2. Effects of fluvastatin on blood glucose and body weight: after 8 weeks of drug intervention, fasting blood glucose level was significantly higher in the diabetic group than the normal control group (P <0.01); fasting blood glucose level in fluvastatin groups had different extent of decline compared with diabetic group (P <0.01); fasting blood glucose level had no significant difference in insulin group and normal control group (P> 0.05). Compared with normal control group, body weight reduced significantly in diabetic model rats (P <0.01); in each group of fluvastatin and diabetic rats there was no significant difference in body weight (P> 0.05); body weight of insulin group was significantly increased (P <0.01), but still less than the normal group (P <0.01).
3. Effects of fluvastatin on diabetic rats testis mass and testicular coefficient: the quality and the coefficient of diabetic model rat testis were significantly lower than the normal control group (P <0.01); testis mass and coefficient in fluvastatin groups were higher than the diabetic model group and 18mg/kg group was significantly different with the diabetic mode group (P <0.01); testis mass was lower in insulin group than normal control group (P <0.01), but there were no significant difference in testis coefficient (P> 0.05).
4. Effects of fluvastatin on sperm parameters in diabetic rats: the sperm count and sperm motility in diabetic model group were significantly less than the normal control group (P <0.01); fluvastatin 6mg/kg group had no significant difference with the diabetic mode group (P> 0.05) of sperm count and sperm motility rate, fluvastatin 18mg/kg group was significantly higher than the diabetic model group (P <0.05 or P <0.01)on these, but less than insulin group (P <0.01). Insulin group‘s sperm count and sperm motility had significant difference with the normal group (P <0.01).
5. Effects of fluvastatin on HE staining of diabetic rat’s testicular tissue:under the light microscopy, the normal rat’s testis seminiferous tubules were full and neatly arranged in spermatogenic cell lumen and the sperm density; the diabetic model group rats’seminiferous tubules were atrophied, germ cells were significant reduced, no sperm in most of the lumens; structure of seminiferous tubules were integrity in fluvastatin groups: mitotic phase of sperm could be seen in 6mg/kg group and some sperms could be seen in 18mg/kg group. The morphologies of spermatogenic cells and seminiferous tubules in insulin group looked like as normal group, more sperm could be seen in the seminiferous tubules.
6. Effects of fluvastatin on TUNEL staining of diabetic rats’spermatogenic cells: the amount of apoptotic cells was the most in the diabetic group, and significantly higher than other groups (P <0.01). After the intervention of fluvastatin, the number of apoptotic spermatogenic cells significantly decreased compared with diabetic model group (P <0.01), and it was better in the 18mg / kg group than 6mg/kg group, but still more than insulin group; The number of apoptotic cells in insulin group was similar to the normal group (P> 0.05).
7. Effects of fluvastatin on testicular tissue ultrastructure of diabetic rats under the electron microscope: in diabetic rats, Leydig cells were shrunk, cytoplasmic reduced, mitochondrial reduced and cristae dissolved, endoplasmic reticulums were expanded, lipid droplets were increased , Leydig cell nuclear pyknosis , chromatin gathered; Interstitial microvascular endothelial cell proliferated and swelled, basement membrane thickened significantly, showing that a large number of cellulose-like substance deposited. In the fluvastatin group ,organelles increased in Leydig cells ,the structure of mitochondrial cristae became more clear, endoplasmic reticulum increased, lipid droplets, the Phenomenon of Leydig cell nuclear pyknosis and Chromatin gathered better than the diabetic group; The interstitial capillary lumen patency, significantly improved in vascular endothelial cells, vascular basement membrane thickening and fibrinoid deposition was significantly reduced. And the 18mg/kg group was better than 6mg/kg group, close to the normal group.The ultrastructure of interstitial cells and interstitial microvasculars in the Insulin group were close to the normal group.
8. Effects of fluvastatin on serum testosterone levels in diabetic rats: testosterone levels in diabetic rats were significantly lower than the normal rats (P <0.01). Testosterone levels were higher in fluvastatin 18mg/kg group than the diabetic model group (P <0.01), but less than insulin group. The testosterone levels of insulin group were lower than the normal group (P <0.05).
9. Effects of fluvastatin on testis tissue SOD, GSH-PX activity and MDA content in diabetic rats: compared with normal rats, SOD levels were significantly lower in diabetic rats than normal rats (P <0.01), GSH-PX and MDA levels were significantly higher than normal rats (P <0.01). SOD were significantly higher in the fluvastatin groups than the diabetic group (P <0.01 or P <0.05), GSH-PX level and MDA level were decreased significantly than the diabetic group (P < 0.05 or P <0.01); The fluvastatin groups have no significant differences with the Insulin group in SOD, GSH-PX and MDA level (P> 0.05).
10. Effects of fluvastatin on Bax, Bcl-2 positive immunohistochemical expression of spermatogenic cells in diabetic rats: In the normal group, Bcl-2 expression was the most and Bax expression was the least, the Bcl-2 expression was significantly decreased and Bax expression was significantly increased in diabetic group than in the other groups (P <0.01). The Bcl-2 expression in fluvastatin group was significantly increased than in the diabetic group (P <0.01), and Bax expression was significantly decreased (P <0.01)than in the diabetic group, the 18mg / kg group was better than 6mg/kg group. Insulin group was better than the fluvastatin group (P <0.01), but there was significant difference with the normal group (P <0.01).
Conclusion
1.Fluvastatin can reduces testicular tissue Injury of diabetic rats, it has a protective effect on testicular tissue.
2.The Protective mechanism of fluvastatin on the testicular tissue in diabetic rats may related to the reduced oxidative stress and regulation of germ cell Bax, Bcl-2 positive cells
引文
[1] Yang W,Lu J,Weng J,et al. Prevalenee of Diabetes among Men and women in China[J].NEngl J Med,2010,362(12):1090-1011.
[2]全国糖尿病研究协作组调查研究组.全国14省市30万人口中糖尿病调查报告[J].中华内科杂志,1981,20(11):678.
[3]向红丁,吴纬,刘灿群,等.1996年全国糖尿病流行病学特点基线调查报告[J].中国糖尿病杂志,1998,6(3):131-133.
[4]柳其中,胡礼泉.糖尿病与勃起功能障碍病因研究进展[J].中华男科学, 2002,8(3): 215-217.
[5] Bener A, Al-Ansari AA, Zirie M, et al. Ismale fertility associated with type 2 diabetes mellitus[J]. Int U rol N ephrol, 2009,41(4): 777-784.
[6] Padrón RS, Dambay A, Suárez R, et al. Semen analyses in adolescent dia- betic patients[J]. Acta DiabetolLat, 1984, 21(2): 115-121.
[7] Baccetti B, La Marca A, Piomboni P, et al. Insulin-dependent diabetes in men isassociated with hypothalamo-pituitary derangement and with imp- airment in semen quality[J].Hum Reprod, 2002, 17(10): 2673-2677.
[8] Hassan AA, Hassouna MM, Taketo T, et al. The effect of diabetes on sexual behavior and reproductive tract function in male rats[J]. J Urol, 1993, 149(1): 148-154.
[9]廖波,邓显忠,杨正伟.糖尿病对精子发生的影响[J].川北医学院学报, 2010, 25 (2): 176-181.
[10]陈锡文,吴晓烨,方周溪,等.实验性2型糖尿病大鼠睾丸Leydig细胞形态和睾酮合成功能的改变[J].温州医学院学报, 2008, 38(4): 317-320.
[11]王忠山,王成忠,左文静,等.青春期糖尿病对鼠睾丸间质细胞功能和细胞核雄激素受体的影响[J].中国病理生理杂志, 1996, 12(6):575-578.
[12]赵红光,朴春南.糖尿病雄性生殖损伤及其发生机制[J].中华男科学, 2004, 10 (10): 767-770.
[13]毛晓明,刘志民.氧化应激在糖尿病糖代谢中的作用[J].江苏医药, 2005, 31 (3): 212-213.
[14] Brownlee M. Biochemistry and molecular cell biology of diabetic comp- lications [J]. Nature, 2001, 414:813-820.
[15] Stadler K, Jenei V, von Bolcshazy G, et al. Role of free radicals and reactive nitrogen species in the late complications of diabetes mell- itus in rats[J]. Orv Hetil, 2004, 145(21):1135-1140.
[16] Pacher P, Liaudet L, Soriano FG, et al. The role of poly(ADP-ribose) polymerase activation in the development of myocardial and endothelial dysfunction in diabetes [J]. Diabetes, 2002, 51(2): 514-521.
[17] Marchioli R, Schweiger C, Levantesi G, et al. Antioxidant vitamins and prevention of cardiovasclar disease: epidemiological and clinical trial data[J]. Lipids, 2001, 36: 53-63.
[18]袁小燕,任跃忠.抗氧化剂治疗糖尿病及其并发症新进展[J].国外医学.老年医学分册, 2007, 28(2): 49-55.
[19]牟忠卿,陈丽.糖尿病与氧化应激[J].国外医学.内分泌学分册, 2005, 25 (6): 393-395.
[20]刘威.抗氧化应激药物防治糖尿病血并发症的研究进展[J].中山大学研究生学刊, 2007, 28(4):17-23.
[21]章飞凤.氟伐他汀的研究进展[J].中国实用医药, 2007, 12(2): 139-141.
[22]鄢华,高炜.他汀类药物作用和作用机制的新认识[J].临床内科杂志, 2006, 23: 5-7.
[23]庞国强.他汀类药物的药理与临床应用[J].中国医药导报, 2010, 7(1):11-15.
[24] Istvan ES, Deisenhofer J. Structural mechanism for statin inhibition ofHMG- CoA reductase [J]. Science, 2001 May 11, 292(5519):1160-1164.
[25]杜静,周钧,杨超,等.他汀改善实验性糖尿病内皮细胞功能的研究[J].中国实验诊断学, 2009, 13(5):584-587.
[26]刘宇宏,曾秋棠,毛晓波,等.氟伐他汀防治缺血性心脏病心衰及其抗氧化应激作用的实验研究[J].心脏杂志, 2005, 17(1):21-28.
[27]王伟超,张洁,刘宽芝,等.氟发他汀对1型糖尿病大鼠血液、尿液结缔组织生长因子表达与肾脏病变干预作用的研究[J].中国现代医学杂志2009, 19(24): 3740-3744.
[28]聂国明,邹敏书,余健.氟伐他汀对糖尿病肾病鼠血管内皮生长因子表达的影响[J].中国药师, 2008, 11(3):265-267.
[29]熊狄,李赟.氟伐他汀对糖尿病大鼠TNF-α表达的干预作用研究[J].江西医药, 2009, 44(5): 438-441.
[30]魏荣锐,苗明三.糖尿病动物模型及特点分析[J].中医研究,2010,23(2):6-11.
[31]阿地力江·伊明,凯赛尔江·多来提,秦永德,等.糖尿病对雄性大鼠睾丸及外周血中性激素水平的影响[J].新疆医科大学学报, 2008, 31(8):931-933.
[32]常利民,董佳生,徐华,等.SD大鼠1型糖尿病动物模型的建立[J].山西医药2009,38(3):218-220.
[33]蒋升,谢自敬,张莉.链脲佐菌素诱导1型糖尿病大鼠模型稳定性观察[J].中国比较医学杂志2006,16(1):16-18.
[34] Ali ST, Shaikh RN, Ashfaqsiddiqi N, et al. Serum and urinary levels of pituitary-gonadal hormones in insulin-dependent and non insulin-dependent diabetic males with and without neuropathy[J]. ArchAndro, 1993, 30(2): 117-123.
[35]刘子红,左文静,许宗革,等.青春期糖尿病鼠垂体——睾丸轴的变化[J].白求恩医科大学学报, 1997, 23(5): 486-488.
[36] Cameron DF, Murray FT, Drylie DD. Interstitial compartment pathologyand spermatogenic disruption in testes from impotent diabetic men [J]. Anat Rec, 1985, 213(1): 53-62.
[37]陈国荣,徐正,毛孙忠,等.糖尿病大鼠睾丸病理变化及脂质过氧化和一氧化氮的改变[J].中国病理生理杂志, 2001, 17(2): 425-427.
[38] Rossi GL, Aeschlimann M. Morphometric studies of pituitary glands and testes in rats with streptozotocin-induced diabetes[J]. Andrologia, 1982, 14(6): 532-542.
[39]其其格,张宝林,乌云.实验性糖尿病大鼠睾丸超微结构变化[J].内蒙古医学杂志, 2007, 39(7):777-779.
[40] Ballester J, Munoz MC, Dominguez J, el al. Insulin-dependent diabetes af- fects testicular function by FSH-and LH-linked mechanisms[J]. J Androl, 2004, 25 (5): 706-719.
[41] Fanuel Lampiao, Stefan S. du Plessis (南非)胰岛素和瘦素能改善人精子的运动力、顶体反应和一氧化氮的产量[J].亚洲男科学杂志, 2008, 10(5): 799-807.
[42] Kim S T, Moley KH. Paternal effect on embryo quality in diabetic mice is related to poor sperm quality and associated with decreased glucose transporter expression [J]. Reproduction. 2008, 136(3): 313-322.
[43]张果平,黄永宏,李峰,等.胰岛素样生长因子家族对动物生殖功能的影响[J].上海畜牧兽医通讯, 2002(1):17-19.
[44]罗龙兴,卢晟盛,许丹娜,等.精子不同处理和胰岛素不同浓度对猪卵母细胞胞质内单精子显微受精的影响[J].中国兽医学报, 2009, 29(5): 669-672.
[45] Doreswamy K, Shrilatha B, Rajeshkumar T, et al. Nickel-induced oxidative stress in testis of mice: evidence of DNA damage and genotoxic effects[J] . J Androl , 2004, 25(6): 996-1003.
[46] Valko M, Leibfritz D, Moneol J, et al. Free radicals and antioxidants innormal physiological functions and human disease[J]. The International Joumal of Bio- chemistry &Cell Biology, 2007, 39(1): 44-48.
[47]龚云,李敏,亢建国.有氧运动以及补充灵芝多糖抗糖尿病大鼠睾丸脂质过氧化机制的探讨[J].甘肃联合大学学报(自然科学版), 2010, 24(4): 79-82.
[48]孙臣友,滕艳杰,李占国.青春期糖尿病鼠血清睾丸附睾组织MDA、GSH-Px及性腺重量的变化[J].黑龙江医药科学, 2001, 24(3): 7-10.
[49]焦士蓉,王波,黄承钰,等. 2糖尿病小鼠模型的组织氧化应激研究[J].现代预防医学, 2009, 36(21): 4136-4138.
[50]舒毅,钟历勇,石立.褪黑素、维生素E和还原型谷胱甘肽对四氧嘧啶糖尿病大鼠氧化应激影响的比较研究[J].东南大学学报(医学版), 2006, 25(2): 88-89.
[51]赵红光,刘光伟,刘淑春,等.患糖尿病12周大鼠睾丸生精细胞周期及其凋亡与抗氧化水平的变化[J].中华男科学杂志, 2005, 10(10): 735-739.
[52] RamahAndran B, Ravi K, Narayanan V, et al. Protective effect of macrocy- clic binuclear oxovanadium complex on oxidative stress in pancreas of streptozotocin induced diabetic rats[J]. Chem Biol Interact, 2004, 149(1): 9-21.
[53]王忠山,赵慧,邹冬辉等.短期糖尿病雄鼠睾丸氧自由基和抗氧化水平的研究[J].中华男科学杂志, 2003, 17(2): 79-81.
[54] Nakashima A, Ohtawa M, Iwasaki K, et al. Inhibitory effects of fluvastain and its metabolites on the formation of several reactive oxygen Species [J]. Life Sc, 2001, 69(12): 1381- 1389.
[55] Nakamura T, Nishi H, et al. Mechanism of antioxidative activity of flu- vastatin- determination of the active position[J]. Chem Pharm Bull (Tokyo), 2000 Feb, 48(2): 235-237.
[56] Oltvai ZN, Milliman CL, Korsmeyer SJ J, et al. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed celldeath[J]. Cell, 1993, 74(4): 609-619.
[57]张莉,朱伟杰.睾丸生精细胞凋亡调控机制的研究进展[J].生殖与避孕, 2005, 25(4): 229-232.
[58] Guneli E, Tugyan K, Ozturk H, et al. Effect of melatonin on testicular damage in streptozotocin-induced diabetes rats[J]. Eur Surg Res, 2008, 40(4): 354-360.
[59]岳凤鸣,庞晓静,高福禄,等. db/db自发性糖尿病小鼠生殖细胞凋亡及相关基因Bcl-2和Bax表达[J].解剖科学进展, 2001, 7(2): 106-110.
[60]赵红光,刘光伟,刘淑春,等.患糖尿病12周大鼠睾丸生精细胞周期及其凋亡与抗氧化水平的变化[J] .中华男科学杂志, 2005, 11(10): 735-739.
[61]曹阳,祁俊生,王远亮.自由基介导细胞凋亡的机制[J] .重庆三峡学院学报,2004, 3(20):118-122.
[62]吴青,冯云,朱晓斌.糖尿病对精液质量的影响及其机制[J].中国优生与遗传杂志, 2009, 17(12): 1-3.
[63]赵慧,王忠山,邹冬辉,等.青春期糖尿病大鼠睾丸的细胞学变化[J].生殖与避孕, 2003, 23(1): 11-16.
[64]黄斌伦,李旭升,陈国荣,等.糖尿病大鼠血、睾丸和脑组织内皮素水平的初步研究[J].心脑血管病防治, 2004, 4(4): 19-21.
[65] Cail, Chen S, Evans T, et al. Apoptotic germ-cell death and testicular da- mage in experimental diabetes: prevention by endothelin antagonism. Urol Res, 2000, 28(5): 342-347.
[66]邱春光,卢长青.糖尿病微血管病变发生机制研究现状[J].心血管病学研究, 2007, 28(1): 13-14.
[67] Swiatkowska M, Pawlowska Z, Szemraj J, et al. Cerivastatin, a HMG CoA reductase inhibitor, reduces plasminogen activator inhibitor-1 (PAI-1) expression in endothelial cells by down regulation of cellular signal-ing and the inhibition of PAIi1 promoter activity[J]. Jpn J Pharmacol, 2002, 90(4): 337-344.
[68] Masamura K, Oida K, Kanehara H, et al. Pitavastatin induced thrombomodu- Lin expression by endothelial cells acts via inhibition of small G proteins of the Rho family[J]. Arterioscler Thromb Vasc Biol, 2003, 23(3): 512-517.
[69] Takemoto M, Liao JK. Pleiotropic effects of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors [J]. ArteriosclerThromb Vasc Biol, 2001, 21(11): 1712-1719.
[70] Lam HC, Chu CH, Wei MC, et al. The effects of different doses of atorvast- atin on plasma endothelini1 levels in type 2 diabetic patients with dysli- pidemia[J]. Exp Biol Med (Maywood), 2006, 231(6): 1010-1015.
[71] Dobrucki LW, Kalinowski L, Dobrucki IT, Malinski T, et al. Statin-stimul- ated nitric oxide release from endothelium [J]. Med Sci Monit, 2001, 7(4): 622-627.
[1] Yang W,Lu J,Weng J,et al. Prevalenee of Diabetes among Men and women in China[J].NEngl J Med,2010,362(12):1090一1011.
[2]潘长玉,金文胜.2型糖尿病流行病学[J].中华内分泌代谢杂志,2005,21(5): 5S1-5S5.
[3]胡善联,刘国恩,许樟荣,等.我国糖尿病流行病学和疾病经济负担研究现状[J].中国卫生经济,2008,25(8):5-8.
[4]柳其中,胡礼泉.糖尿病与勃起功能障碍病因研究进展[J].中华男科学, 2002,8(3): 215-217.
[5] BenerA, Al-AnsariAA, ZirieM, et al. Ismale fertility associated with type 2 diabetes mellitus[J].Int U rol N ephro,l 2009,41(4): 777-784.
[6] Padrón RS, DambayA, SuárezR, et al. Semen analyses in adolescent diabetic patients[J]. Acta DiabetolLat,1984,21(2): 115-121.
[7] Baccetti B, La Marca A, Piomboni P, et al. Insulin-dependent diabetes in men isassociated with hypothalamo-pituitary derangement and with impair- rmen in semen quality[J].Hum Reprod,2002,17(10): 2673-2677.
[8]张仁东,王亚平,杨正伟.雄孕激素男性避孕研究进展[J].中国计划生育学杂志, 2004, 12 (12): 758-761.
[9] ThielW, L wO, Schreiber G. Testicular biopsies inmale diabetics[J].Gesamte InnMed, 1981, 36(23): 917-920.
[10] Cameron DF, Murray FT, Drylie DD. Interstitial compartment pathology and spermatogenic disruption in testes from impotent diabetic men [J].Anat Rec, 1985,213(1): 53-62.
[11] Liu SH, Wang ZS. Study on the expression of androgen receptor in testis, epididymis and prostate of adult rats with diabetes[J].Zhonghua Nan Ke Xue,2005,11(12):891-894.
[12] AltubasK, NurZ. Amorphological study of the testis in streptozotoc in diabetic mouse[J].Indian Veterinary Journal, 2006, 88 (11):1201-1203.
[13]陈国荣,徐正,毛孙忠,等.糖尿病大鼠睾丸病理变化及脂质过氧化和一氧化氮的改变[J].中国病理生理杂志,2001,17(2):425-427.
[14] Gondos B, Rivkind Y, Jovanovic L. Effect of increasing glucose concentrations on sertoli cell viability in the nonobese diabetic mouse [J]. Ann Clin Lab Sci, 1998, 28(4): 236-241.
[15] BaccettiB, LaMarca A, Piomboni P, et al. Insulin-dependent diabetes in men is associated with hypothalamo-pituitary derangement and with impairment in semen quality[J].Hum Reprod, 2002, 17(10): 2673-2677.
[16] Rossi GL, Aeschlimann M. Morphometric studies of pituitary glands and testes in rats with streptozotocin-induced diabetes[J].Andrologia. 1982, 14(6): 532-542.
[17]陈锡文,吴晓烨,方周溪,等.实验性2型糖尿病大鼠睾丸Leydig细胞形态和睾酮合成功能改变[J].温州医学院学报,2008,38(4):317-320.
[18]其其格,张宝林,乌云.实验性糖尿病大鼠睾丸超微结构变化[J].内蒙古医学杂志,2007,39(7):777-779.
[19] Anderson JE, Thliveris JA. Testicular histology in streptozotocin-induced diabetes[J].AnatRec, 1986, 214(4): 378-382.
[20] Ballester J, Mu oz MC, Dominguez J, el al. Insulin-dependent diabetes affects testicular function by FSH-and LH-linked mechanisms[J].J Androl, 2004, 25(5): 706-719.
[21]郭应禄,胡礼泉.《男科学》[M].第三版,北京:人民卫生出版社,2004:50-51.
[22] Skinner MK. Cell-cell interactions in the testis [J]. EndocrineReviews 1991, 12(1): 45-77.
[23] Cameron DF, Murray FT, Drylie DD. Ultrastructural lesions intestes fromhyperprolactinemicmen [J].J Andro, l 1984, 5(4):283-293.
[24]王忠山,王成忠,左文静.青春期糖尿病对鼠睾丸间质细胞功能和细胞核雄激素受体的影响[J].中国病理生理杂志, 1996, 12(6): 575-578.
[25]杨力,王忠山,许宗革,等.青春期糖尿病鼠睾丸支持细胞功能研究[J].白求恩医科大学学报, 1996, 22(2): 113-115.
[26] Sudha S, Valli G, Aprie PM, et al. Influence of streptozotocin-induced diabetes and insulin treatment on the pituitary-testicular axis during sexual maturation in rats [J].Exp Clin Endocrinol Diabetes, 2000, 108(1): 14-20.
[27]阿地力江·伊明,凯赛尔江·多来提,秦永德,等.糖尿病对雄性大鼠睾丸及外周血中性激素水平的影响[J].新疆医科大学学报, 2008, 31(8): 931-933.
[28] García-DíezL C, CorralesHernandez JJ,Hernandez-Diaz J,et al.Semen chara- cteristics and diabetes mellitus, significance of insulin in male infertility[J].ArchAndrol, 1991, 26(2): 119-128.
[29] Brownlee M. Biochemistry and molecular cell biology of diabetic compli- cations[J].Nature, 2001, 414:813-820.
[30]舒毅,钟历勇.氧化应激与糖尿病[J].东南大学学报:医学版,2005,24(1):64-67.
[31]王忠山,赵慧,邹冬辉,等.短期糖尿病雄鼠睾丸氧自由基和抗氧化水平的研究[J].中国男科学杂志, 2003, 17(2): 79-81.
[32] Shrilatha B, Muralidhara.Early oxidative stress in testis and epididymal sperm in streptozotocin- induced diabetic mice: Its progression and genotoxic consequences[J].Reprod Toxicol, 2007, 23(4): 578-587.
[33] Aybek H, Aybek Z, Rota S, et.al. The effects of diabetes mellitus, age, and vitamin E on testicular oxidative stress[J].Fertil Steril, 2008, 90(3): 755-760.
[34] Thyagaraju BM, Muralidhara.Ferulic acid supplements abrogate oxidativeimpairments in liver and testis in the streptozotocin-diabetic rat [J]. Zoolog Sci, 2008,25(8): 854-860.
[35]赵红光,刘光伟,刘淑春,等.患糖尿病12周大鼠睾丸生精细胞周期及其凋亡与抗氧化水平的变化[J].中华男科学杂志,2005, 11(10): 735-739.
[36]Tang XY, Zhang Q, Dai DZ, et al. Effects of strontium fructose 1,6- diphosphate on expression of apoptosis-related genes and oxidative stress in testes of diabetic rats[J].Int J Urol, 2008, 15(3): 251-256.
[37] Armagan A, Uz E, Yilmaz HR, et al. Effects of melatonin on lipid peroxidation and antioxidant enzymes in streptozotocin-induced diabetic rat testis [J].Asian J Androl, 2006, 8(5): 595-600.
[38]Guneli E, Tugyan K, Ozturk H, et al. Effect of melatonin on testicular damage in streptozotocin-induced diabetes rats[J]. Eur Surg Res, 2008, 40(4): 354 -360.
[39]牟忠卿,陈丽.糖尿病中氧化应激的研究进展[J].国外医学.内科学分册, 2005, 32 (12): 510-512.
[40]渠莉,王津文,于飞.他汀类药物的非调脂机制研究进展[J].中国医药, 2006, 1 (6): 379-381.
[41] Nakamura T, Nishi H, et al. Mechanism of antioxidative activity of fluvastatin-determination of the active position[J]. Chem Pharm Bull (Tokyo). 2000 Feb, 48(2): 235-237.
[42] Yilmaz MI, Baykal Y Kilic M, et al. Effects of statins on oxidative stress [J].Biol Trace Elem Res, 2004, 98(2): 119-127.
[43] Stoll LL, McCormick ML, Denning GM, et al. Antioxidant efiects of statins[J]. Drugs Today(Barc), 2004, 40(12): 975-990.
[44] Davignon J, Jacob RF, Mason RP. The antioxidant effects of statins[J].Coron Artery Dis, 2004, 15(5): 251-258.
[45] Takemoto M, Liao JK. Pleiotropic effects of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors[J].Arterioscler Thromb Vasc Biol, 2001, 21(11): 1712-1719.
[46] Dobrucki LW, Kalinowski L, Dobrucki IT, Malinski T, et al. Statin-stimulated nitric oxide release from endothelium[J].Med Sci Monit, 2001, 7(4): 622 -627.
[47] Ceriello A,Taboga C,Tonutti L,et al. Evidence for an Independent and Cumulative Effect of Postprandial Hypertriglyceridemia and Hyperglycemia on Endothelial Dysfunction and Oxidative Stress Generation [J].cirulat- ion,2002,106(10):1211-1218.
[48] Takemoto M, Node K, Nakagami H, et al. Statins as antioxidant therapy for preventing cardiac myocyte hypertrophy [J].J Clin Invest, 200l,108(10): 1429-1437.
[49]刘宇宏,曾秋棠,毛晓波,等.氟伐他汀防治缺血性心脏病心衰及其抗氧化应激作用的实验研究[J].心脏杂志,2005,17(1): 21-24.
[50]赵志宏,单江,项美香,等.氟伐他汀抗氧化改善心肌梗死大鼠心室重塑[J].浙江大学学报(医学版),2005,34(5): 447-453.
[51]周营,苏青,王瑞良.氟伐他汀对糖尿病大鼠尿蛋白排泄率及肾组织氧化应激等的影响[J].实用糖尿病杂志, 2006, 2(3): 62-63.
[52]刘威.抗氧化应激药物防治糖尿病血并发症的研究进展[J].中山大学研究生学刊, 2007,28(4):17-23.
[53]杜静,周钧,杨超,等.他汀改善实验性糖尿病内皮细胞功能的研究[J].中国实验诊断学, 2009,13(5):584-587.
[2]全国糖尿病研究协作组调查研究组.全国14省市30万人口中糖尿病调查报告[J].中华内科杂志,1981,20(11):678.
[3]向红丁,吴纬,刘灿群,等.1996年全国糖尿病流行病学特点基线调查报告[J].中国糖尿病杂志,1998,6(3):131-133.
[4]柳其中,胡礼泉.糖尿病与勃起功能障碍病因研究进展[J].中华男科学, 2002,8(3): 215-217.
[5] Bener A, Al-Ansari AA, Zirie M, et al. Ismale fertility associated with type 2 diabetes mellitus[J]. Int U rol N ephrol, 2009,41(4): 777-784.
[6] Padrón RS, Dambay A, Suárez R, et al. Semen analyses in adolescent dia- betic patients[J]. Acta DiabetolLat, 1984, 21(2): 115-121.
[7] Baccetti B, La Marca A, Piomboni P, et al. Insulin-dependent diabetes in men isassociated with hypothalamo-pituitary derangement and with imp- airment in semen quality[J].Hum Reprod, 2002, 17(10): 2673-2677.
[8] Hassan AA, Hassouna MM, Taketo T, et al. The effect of diabetes on sexual behavior and reproductive tract function in male rats[J]. J Urol, 1993, 149(1): 148-154.
[9]廖波,邓显忠,杨正伟.糖尿病对精子发生的影响[J].川北医学院学报, 2010, 25 (2): 176-181.
[10]陈锡文,吴晓烨,方周溪,等.实验性2型糖尿病大鼠睾丸Leydig细胞形态和睾酮合成功能的改变[J].温州医学院学报, 2008, 38(4): 317-320.
[11]王忠山,王成忠,左文静,等.青春期糖尿病对鼠睾丸间质细胞功能和细胞核雄激素受体的影响[J].中国病理生理杂志, 1996, 12(6):575-578.
[12]赵红光,朴春南.糖尿病雄性生殖损伤及其发生机制[J].中华男科学, 2004, 10 (10): 767-770.
[13]毛晓明,刘志民.氧化应激在糖尿病糖代谢中的作用[J].江苏医药, 2005, 31 (3): 212-213.
[14] Brownlee M. Biochemistry and molecular cell biology of diabetic comp- lications [J]. Nature, 2001, 414:813-820.
[15] Stadler K, Jenei V, von Bolcshazy G, et al. Role of free radicals and reactive nitrogen species in the late complications of diabetes mell- itus in rats[J]. Orv Hetil, 2004, 145(21):1135-1140.
[16] Pacher P, Liaudet L, Soriano FG, et al. The role of poly(ADP-ribose) polymerase activation in the development of myocardial and endothelial dysfunction in diabetes [J]. Diabetes, 2002, 51(2): 514-521.
[17] Marchioli R, Schweiger C, Levantesi G, et al. Antioxidant vitamins and prevention of cardiovasclar disease: epidemiological and clinical trial data[J]. Lipids, 2001, 36: 53-63.
[18]袁小燕,任跃忠.抗氧化剂治疗糖尿病及其并发症新进展[J].国外医学.老年医学分册, 2007, 28(2): 49-55.
[19]牟忠卿,陈丽.糖尿病与氧化应激[J].国外医学.内分泌学分册, 2005, 25 (6): 393-395.
[20]刘威.抗氧化应激药物防治糖尿病血并发症的研究进展[J].中山大学研究生学刊, 2007, 28(4):17-23.
[21]章飞凤.氟伐他汀的研究进展[J].中国实用医药, 2007, 12(2): 139-141.
[22]鄢华,高炜.他汀类药物作用和作用机制的新认识[J].临床内科杂志, 2006, 23: 5-7.
[23]庞国强.他汀类药物的药理与临床应用[J].中国医药导报, 2010, 7(1):11-15.
[24] Istvan ES, Deisenhofer J. Structural mechanism for statin inhibition ofHMG- CoA reductase [J]. Science, 2001 May 11, 292(5519):1160-1164.
[25]杜静,周钧,杨超,等.他汀改善实验性糖尿病内皮细胞功能的研究[J].中国实验诊断学, 2009, 13(5):584-587.
[26]刘宇宏,曾秋棠,毛晓波,等.氟伐他汀防治缺血性心脏病心衰及其抗氧化应激作用的实验研究[J].心脏杂志, 2005, 17(1):21-28.
[27]王伟超,张洁,刘宽芝,等.氟发他汀对1型糖尿病大鼠血液、尿液结缔组织生长因子表达与肾脏病变干预作用的研究[J].中国现代医学杂志2009, 19(24): 3740-3744.
[28]聂国明,邹敏书,余健.氟伐他汀对糖尿病肾病鼠血管内皮生长因子表达的影响[J].中国药师, 2008, 11(3):265-267.
[29]熊狄,李赟.氟伐他汀对糖尿病大鼠TNF-α表达的干预作用研究[J].江西医药, 2009, 44(5): 438-441.
[30]魏荣锐,苗明三.糖尿病动物模型及特点分析[J].中医研究,2010,23(2):6-11.
[31]阿地力江·伊明,凯赛尔江·多来提,秦永德,等.糖尿病对雄性大鼠睾丸及外周血中性激素水平的影响[J].新疆医科大学学报, 2008, 31(8):931-933.
[32]常利民,董佳生,徐华,等.SD大鼠1型糖尿病动物模型的建立[J].山西医药2009,38(3):218-220.
[33]蒋升,谢自敬,张莉.链脲佐菌素诱导1型糖尿病大鼠模型稳定性观察[J].中国比较医学杂志2006,16(1):16-18.
[34] Ali ST, Shaikh RN, Ashfaqsiddiqi N, et al. Serum and urinary levels of pituitary-gonadal hormones in insulin-dependent and non insulin-dependent diabetic males with and without neuropathy[J]. ArchAndro, 1993, 30(2): 117-123.
[35]刘子红,左文静,许宗革,等.青春期糖尿病鼠垂体——睾丸轴的变化[J].白求恩医科大学学报, 1997, 23(5): 486-488.
[36] Cameron DF, Murray FT, Drylie DD. Interstitial compartment pathologyand spermatogenic disruption in testes from impotent diabetic men [J]. Anat Rec, 1985, 213(1): 53-62.
[37]陈国荣,徐正,毛孙忠,等.糖尿病大鼠睾丸病理变化及脂质过氧化和一氧化氮的改变[J].中国病理生理杂志, 2001, 17(2): 425-427.
[38] Rossi GL, Aeschlimann M. Morphometric studies of pituitary glands and testes in rats with streptozotocin-induced diabetes[J]. Andrologia, 1982, 14(6): 532-542.
[39]其其格,张宝林,乌云.实验性糖尿病大鼠睾丸超微结构变化[J].内蒙古医学杂志, 2007, 39(7):777-779.
[40] Ballester J, Munoz MC, Dominguez J, el al. Insulin-dependent diabetes af- fects testicular function by FSH-and LH-linked mechanisms[J]. J Androl, 2004, 25 (5): 706-719.
[41] Fanuel Lampiao, Stefan S. du Plessis (南非)胰岛素和瘦素能改善人精子的运动力、顶体反应和一氧化氮的产量[J].亚洲男科学杂志, 2008, 10(5): 799-807.
[42] Kim S T, Moley KH. Paternal effect on embryo quality in diabetic mice is related to poor sperm quality and associated with decreased glucose transporter expression [J]. Reproduction. 2008, 136(3): 313-322.
[43]张果平,黄永宏,李峰,等.胰岛素样生长因子家族对动物生殖功能的影响[J].上海畜牧兽医通讯, 2002(1):17-19.
[44]罗龙兴,卢晟盛,许丹娜,等.精子不同处理和胰岛素不同浓度对猪卵母细胞胞质内单精子显微受精的影响[J].中国兽医学报, 2009, 29(5): 669-672.
[45] Doreswamy K, Shrilatha B, Rajeshkumar T, et al. Nickel-induced oxidative stress in testis of mice: evidence of DNA damage and genotoxic effects[J] . J Androl , 2004, 25(6): 996-1003.
[46] Valko M, Leibfritz D, Moneol J, et al. Free radicals and antioxidants innormal physiological functions and human disease[J]. The International Joumal of Bio- chemistry &Cell Biology, 2007, 39(1): 44-48.
[47]龚云,李敏,亢建国.有氧运动以及补充灵芝多糖抗糖尿病大鼠睾丸脂质过氧化机制的探讨[J].甘肃联合大学学报(自然科学版), 2010, 24(4): 79-82.
[48]孙臣友,滕艳杰,李占国.青春期糖尿病鼠血清睾丸附睾组织MDA、GSH-Px及性腺重量的变化[J].黑龙江医药科学, 2001, 24(3): 7-10.
[49]焦士蓉,王波,黄承钰,等. 2糖尿病小鼠模型的组织氧化应激研究[J].现代预防医学, 2009, 36(21): 4136-4138.
[50]舒毅,钟历勇,石立.褪黑素、维生素E和还原型谷胱甘肽对四氧嘧啶糖尿病大鼠氧化应激影响的比较研究[J].东南大学学报(医学版), 2006, 25(2): 88-89.
[51]赵红光,刘光伟,刘淑春,等.患糖尿病12周大鼠睾丸生精细胞周期及其凋亡与抗氧化水平的变化[J].中华男科学杂志, 2005, 10(10): 735-739.
[52] RamahAndran B, Ravi K, Narayanan V, et al. Protective effect of macrocy- clic binuclear oxovanadium complex on oxidative stress in pancreas of streptozotocin induced diabetic rats[J]. Chem Biol Interact, 2004, 149(1): 9-21.
[53]王忠山,赵慧,邹冬辉等.短期糖尿病雄鼠睾丸氧自由基和抗氧化水平的研究[J].中华男科学杂志, 2003, 17(2): 79-81.
[54] Nakashima A, Ohtawa M, Iwasaki K, et al. Inhibitory effects of fluvastain and its metabolites on the formation of several reactive oxygen Species [J]. Life Sc, 2001, 69(12): 1381- 1389.
[55] Nakamura T, Nishi H, et al. Mechanism of antioxidative activity of flu- vastatin- determination of the active position[J]. Chem Pharm Bull (Tokyo), 2000 Feb, 48(2): 235-237.
[56] Oltvai ZN, Milliman CL, Korsmeyer SJ J, et al. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed celldeath[J]. Cell, 1993, 74(4): 609-619.
[57]张莉,朱伟杰.睾丸生精细胞凋亡调控机制的研究进展[J].生殖与避孕, 2005, 25(4): 229-232.
[58] Guneli E, Tugyan K, Ozturk H, et al. Effect of melatonin on testicular damage in streptozotocin-induced diabetes rats[J]. Eur Surg Res, 2008, 40(4): 354-360.
[59]岳凤鸣,庞晓静,高福禄,等. db/db自发性糖尿病小鼠生殖细胞凋亡及相关基因Bcl-2和Bax表达[J].解剖科学进展, 2001, 7(2): 106-110.
[60]赵红光,刘光伟,刘淑春,等.患糖尿病12周大鼠睾丸生精细胞周期及其凋亡与抗氧化水平的变化[J] .中华男科学杂志, 2005, 11(10): 735-739.
[61]曹阳,祁俊生,王远亮.自由基介导细胞凋亡的机制[J] .重庆三峡学院学报,2004, 3(20):118-122.
[62]吴青,冯云,朱晓斌.糖尿病对精液质量的影响及其机制[J].中国优生与遗传杂志, 2009, 17(12): 1-3.
[63]赵慧,王忠山,邹冬辉,等.青春期糖尿病大鼠睾丸的细胞学变化[J].生殖与避孕, 2003, 23(1): 11-16.
[64]黄斌伦,李旭升,陈国荣,等.糖尿病大鼠血、睾丸和脑组织内皮素水平的初步研究[J].心脑血管病防治, 2004, 4(4): 19-21.
[65] Cail, Chen S, Evans T, et al. Apoptotic germ-cell death and testicular da- mage in experimental diabetes: prevention by endothelin antagonism. Urol Res, 2000, 28(5): 342-347.
[66]邱春光,卢长青.糖尿病微血管病变发生机制研究现状[J].心血管病学研究, 2007, 28(1): 13-14.
[67] Swiatkowska M, Pawlowska Z, Szemraj J, et al. Cerivastatin, a HMG CoA reductase inhibitor, reduces plasminogen activator inhibitor-1 (PAI-1) expression in endothelial cells by down regulation of cellular signal-ing and the inhibition of PAIi1 promoter activity[J]. Jpn J Pharmacol, 2002, 90(4): 337-344.
[68] Masamura K, Oida K, Kanehara H, et al. Pitavastatin induced thrombomodu- Lin expression by endothelial cells acts via inhibition of small G proteins of the Rho family[J]. Arterioscler Thromb Vasc Biol, 2003, 23(3): 512-517.
[69] Takemoto M, Liao JK. Pleiotropic effects of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors [J]. ArteriosclerThromb Vasc Biol, 2001, 21(11): 1712-1719.
[70] Lam HC, Chu CH, Wei MC, et al. The effects of different doses of atorvast- atin on plasma endothelini1 levels in type 2 diabetic patients with dysli- pidemia[J]. Exp Biol Med (Maywood), 2006, 231(6): 1010-1015.
[71] Dobrucki LW, Kalinowski L, Dobrucki IT, Malinski T, et al. Statin-stimul- ated nitric oxide release from endothelium [J]. Med Sci Monit, 2001, 7(4): 622-627.
[1] Yang W,Lu J,Weng J,et al. Prevalenee of Diabetes among Men and women in China[J].NEngl J Med,2010,362(12):1090一1011.
[2]潘长玉,金文胜.2型糖尿病流行病学[J].中华内分泌代谢杂志,2005,21(5): 5S1-5S5.
[3]胡善联,刘国恩,许樟荣,等.我国糖尿病流行病学和疾病经济负担研究现状[J].中国卫生经济,2008,25(8):5-8.
[4]柳其中,胡礼泉.糖尿病与勃起功能障碍病因研究进展[J].中华男科学, 2002,8(3): 215-217.
[5] BenerA, Al-AnsariAA, ZirieM, et al. Ismale fertility associated with type 2 diabetes mellitus[J].Int U rol N ephro,l 2009,41(4): 777-784.
[6] Padrón RS, DambayA, SuárezR, et al. Semen analyses in adolescent diabetic patients[J]. Acta DiabetolLat,1984,21(2): 115-121.
[7] Baccetti B, La Marca A, Piomboni P, et al. Insulin-dependent diabetes in men isassociated with hypothalamo-pituitary derangement and with impair- rmen in semen quality[J].Hum Reprod,2002,17(10): 2673-2677.
[8]张仁东,王亚平,杨正伟.雄孕激素男性避孕研究进展[J].中国计划生育学杂志, 2004, 12 (12): 758-761.
[9] ThielW, L wO, Schreiber G. Testicular biopsies inmale diabetics[J].Gesamte InnMed, 1981, 36(23): 917-920.
[10] Cameron DF, Murray FT, Drylie DD. Interstitial compartment pathology and spermatogenic disruption in testes from impotent diabetic men [J].Anat Rec, 1985,213(1): 53-62.
[11] Liu SH, Wang ZS. Study on the expression of androgen receptor in testis, epididymis and prostate of adult rats with diabetes[J].Zhonghua Nan Ke Xue,2005,11(12):891-894.
[12] AltubasK, NurZ. Amorphological study of the testis in streptozotoc in diabetic mouse[J].Indian Veterinary Journal, 2006, 88 (11):1201-1203.
[13]陈国荣,徐正,毛孙忠,等.糖尿病大鼠睾丸病理变化及脂质过氧化和一氧化氮的改变[J].中国病理生理杂志,2001,17(2):425-427.
[14] Gondos B, Rivkind Y, Jovanovic L. Effect of increasing glucose concentrations on sertoli cell viability in the nonobese diabetic mouse [J]. Ann Clin Lab Sci, 1998, 28(4): 236-241.
[15] BaccettiB, LaMarca A, Piomboni P, et al. Insulin-dependent diabetes in men is associated with hypothalamo-pituitary derangement and with impairment in semen quality[J].Hum Reprod, 2002, 17(10): 2673-2677.
[16] Rossi GL, Aeschlimann M. Morphometric studies of pituitary glands and testes in rats with streptozotocin-induced diabetes[J].Andrologia. 1982, 14(6): 532-542.
[17]陈锡文,吴晓烨,方周溪,等.实验性2型糖尿病大鼠睾丸Leydig细胞形态和睾酮合成功能改变[J].温州医学院学报,2008,38(4):317-320.
[18]其其格,张宝林,乌云.实验性糖尿病大鼠睾丸超微结构变化[J].内蒙古医学杂志,2007,39(7):777-779.
[19] Anderson JE, Thliveris JA. Testicular histology in streptozotocin-induced diabetes[J].AnatRec, 1986, 214(4): 378-382.
[20] Ballester J, Mu oz MC, Dominguez J, el al. Insulin-dependent diabetes affects testicular function by FSH-and LH-linked mechanisms[J].J Androl, 2004, 25(5): 706-719.
[21]郭应禄,胡礼泉.《男科学》[M].第三版,北京:人民卫生出版社,2004:50-51.
[22] Skinner MK. Cell-cell interactions in the testis [J]. EndocrineReviews 1991, 12(1): 45-77.
[23] Cameron DF, Murray FT, Drylie DD. Ultrastructural lesions intestes fromhyperprolactinemicmen [J].J Andro, l 1984, 5(4):283-293.
[24]王忠山,王成忠,左文静.青春期糖尿病对鼠睾丸间质细胞功能和细胞核雄激素受体的影响[J].中国病理生理杂志, 1996, 12(6): 575-578.
[25]杨力,王忠山,许宗革,等.青春期糖尿病鼠睾丸支持细胞功能研究[J].白求恩医科大学学报, 1996, 22(2): 113-115.
[26] Sudha S, Valli G, Aprie PM, et al. Influence of streptozotocin-induced diabetes and insulin treatment on the pituitary-testicular axis during sexual maturation in rats [J].Exp Clin Endocrinol Diabetes, 2000, 108(1): 14-20.
[27]阿地力江·伊明,凯赛尔江·多来提,秦永德,等.糖尿病对雄性大鼠睾丸及外周血中性激素水平的影响[J].新疆医科大学学报, 2008, 31(8): 931-933.
[28] García-DíezL C, CorralesHernandez JJ,Hernandez-Diaz J,et al.Semen chara- cteristics and diabetes mellitus, significance of insulin in male infertility[J].ArchAndrol, 1991, 26(2): 119-128.
[29] Brownlee M. Biochemistry and molecular cell biology of diabetic compli- cations[J].Nature, 2001, 414:813-820.
[30]舒毅,钟历勇.氧化应激与糖尿病[J].东南大学学报:医学版,2005,24(1):64-67.
[31]王忠山,赵慧,邹冬辉,等.短期糖尿病雄鼠睾丸氧自由基和抗氧化水平的研究[J].中国男科学杂志, 2003, 17(2): 79-81.
[32] Shrilatha B, Muralidhara.Early oxidative stress in testis and epididymal sperm in streptozotocin- induced diabetic mice: Its progression and genotoxic consequences[J].Reprod Toxicol, 2007, 23(4): 578-587.
[33] Aybek H, Aybek Z, Rota S, et.al. The effects of diabetes mellitus, age, and vitamin E on testicular oxidative stress[J].Fertil Steril, 2008, 90(3): 755-760.
[34] Thyagaraju BM, Muralidhara.Ferulic acid supplements abrogate oxidativeimpairments in liver and testis in the streptozotocin-diabetic rat [J]. Zoolog Sci, 2008,25(8): 854-860.
[35]赵红光,刘光伟,刘淑春,等.患糖尿病12周大鼠睾丸生精细胞周期及其凋亡与抗氧化水平的变化[J].中华男科学杂志,2005, 11(10): 735-739.
[36]Tang XY, Zhang Q, Dai DZ, et al. Effects of strontium fructose 1,6- diphosphate on expression of apoptosis-related genes and oxidative stress in testes of diabetic rats[J].Int J Urol, 2008, 15(3): 251-256.
[37] Armagan A, Uz E, Yilmaz HR, et al. Effects of melatonin on lipid peroxidation and antioxidant enzymes in streptozotocin-induced diabetic rat testis [J].Asian J Androl, 2006, 8(5): 595-600.
[38]Guneli E, Tugyan K, Ozturk H, et al. Effect of melatonin on testicular damage in streptozotocin-induced diabetes rats[J]. Eur Surg Res, 2008, 40(4): 354 -360.
[39]牟忠卿,陈丽.糖尿病中氧化应激的研究进展[J].国外医学.内科学分册, 2005, 32 (12): 510-512.
[40]渠莉,王津文,于飞.他汀类药物的非调脂机制研究进展[J].中国医药, 2006, 1 (6): 379-381.
[41] Nakamura T, Nishi H, et al. Mechanism of antioxidative activity of fluvastatin-determination of the active position[J]. Chem Pharm Bull (Tokyo). 2000 Feb, 48(2): 235-237.
[42] Yilmaz MI, Baykal Y Kilic M, et al. Effects of statins on oxidative stress [J].Biol Trace Elem Res, 2004, 98(2): 119-127.
[43] Stoll LL, McCormick ML, Denning GM, et al. Antioxidant efiects of statins[J]. Drugs Today(Barc), 2004, 40(12): 975-990.
[44] Davignon J, Jacob RF, Mason RP. The antioxidant effects of statins[J].Coron Artery Dis, 2004, 15(5): 251-258.
[45] Takemoto M, Liao JK. Pleiotropic effects of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors[J].Arterioscler Thromb Vasc Biol, 2001, 21(11): 1712-1719.
[46] Dobrucki LW, Kalinowski L, Dobrucki IT, Malinski T, et al. Statin-stimulated nitric oxide release from endothelium[J].Med Sci Monit, 2001, 7(4): 622 -627.
[47] Ceriello A,Taboga C,Tonutti L,et al. Evidence for an Independent and Cumulative Effect of Postprandial Hypertriglyceridemia and Hyperglycemia on Endothelial Dysfunction and Oxidative Stress Generation [J].cirulat- ion,2002,106(10):1211-1218.
[48] Takemoto M, Node K, Nakagami H, et al. Statins as antioxidant therapy for preventing cardiac myocyte hypertrophy [J].J Clin Invest, 200l,108(10): 1429-1437.
[49]刘宇宏,曾秋棠,毛晓波,等.氟伐他汀防治缺血性心脏病心衰及其抗氧化应激作用的实验研究[J].心脏杂志,2005,17(1): 21-24.
[50]赵志宏,单江,项美香,等.氟伐他汀抗氧化改善心肌梗死大鼠心室重塑[J].浙江大学学报(医学版),2005,34(5): 447-453.
[51]周营,苏青,王瑞良.氟伐他汀对糖尿病大鼠尿蛋白排泄率及肾组织氧化应激等的影响[J].实用糖尿病杂志, 2006, 2(3): 62-63.
[52]刘威.抗氧化应激药物防治糖尿病血并发症的研究进展[J].中山大学研究生学刊, 2007,28(4):17-23.
[53]杜静,周钧,杨超,等.他汀改善实验性糖尿病内皮细胞功能的研究[J].中国实验诊断学, 2009,13(5):584-587.